Table 2.
General and clinical characteristics of COVID-19 patients.
| Patients’ characteristics (n = 15) | Statistics |
|
|---|---|---|
| Mean | Std. Deviation | |
| Age (8 months-56 years) | 28.06 | 16.42 |
| Number | Percentage | |
| Age categories n (%) | ||
| 0–5 years | 2 | 13.3 |
| 6–18 years | 2 | 13.3 |
| 19–50 years | 10 | 66.7 |
| 51–64 years | 1 | 6.7 |
| Gender | ||
| Male | 9 | 60.0 |
| Female | 6 | 40.0 |
| Disease Stage | ||
| Mild | 13 | 86.7 |
| Mild-Moderate | 1 | 6.7 |
| Moderate-Severe | 1 | 6.7 |
| Clinical Symptoms n (%) | ||
| Fever | 8 | 53.3 |
| Cough | 7 | 46.7 |
| Shortness of breath | 3 | 20.0 |
| Fatigue | 3 | 20.0 |
| Sore throat | 1 | 6.7 |
| Chill | 1 | 6.7 |
| Rhinorrhea | 2 | 13.3 |
| Other symptoms (Taste and smell disorders) | 4 | 26.7 |
| Type of infection, n (%) | ||
| Symptomatic | 9 | 60.0 |
| Asymptomatic | 6 | 40.0 |
| Clinical outcome, n (%) | ||
| Recovered and discharged | 15 | 100 |
| Died in hospital | 0 | 0.0 |
| Admitted to ICU | 0 | 0.0 |
| Required ICU care | 0 | 0.0 |
| Required assisted ventilation | 0 | 0 |
| Complications related to Covid-19 | ||
| Acute lung injury/ARDS | 0 | 0.0 |
| Acute kidney injury | 0 | 0.0 |
| Liver dysfunction | 0 | 0.0 |
| Rhabdomyolysis | 0 | 0.0 |
| Pneumothorax | 0 | 0.0 |
| Arrhythmias | 0 | 0.0 |
| Sepsis | 0 | 0.0 |
| Seizures | 0 | 0.0 |
| Time from illness diagnosis to discharge (Range: 8–21 days) | Median: 8.0 | Interquartile range: 3.25 |